Evommune, Inc. (EVMN)

12.50 +0.02 (+0.12%) USD  |  NYSE  |  Sep 02, 16:00
12.50 0.00 (0.00%) After-Hours: 19:31
More

Evommune Operating Income (Annual)

Operating Income (Annual) Chart

View Operating Income (Annual) for EVMN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Operating Income (Annual) Chart
Start Trial

Historical Operating Income (Annual) Data

View and export this data back to 2023. Start Trial.
Date Value
December 31, 2025 --
December 31, 2024 --
Date Value
December 31, 2023 --

Operating Income (Annual) Range, Past 5 Years

View Operating Income (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Operating Income (Annual) Benchmarks

View Operating Income (Annual) Benchmarks
Start Trial
MapLight Therapeutics, Inc. Upgrade
Mineralys Therapeutics, Inc. Upgrade
Arrowhead Pharmaceuticals, Inc. Upgrade
Oncolytics Biotech, Inc. Upgrade
Sangamo Therapeutics, Inc. Upgrade